JSP
PTLA

Jackson Square Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Jackson Square Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,488,146
Closed -$24.9M – 96
2020
Q1 		$24.9M Buy
3,488,146
+32,111
+0.9% +$401K 0.16% 74
2019
Q4 		$82.5M Buy
3,456,035
+229,922
+7% +$6.34M 0.43% 57
2019
Q3 		$86.5M Buy
3,226,113
+679,781
+27% +$19.1M 0.48% 52
2019
Q2 		$69.1M Buy
2,546,332
+681,599
+37% +$21.4M 0.36% 69
2019
Q1 		$64.7M Sell
1,864,733
-76,293
-4% -$2.2M 0.35% 68
2018
Q4 		$37.9M Buy
1,941,026
+929,982
+92% +$19.1M 0.23% 74
2018
Q3 		$26.9M Buy
+1,011,044
New +$33M 0.14% 76

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Jackson Square Partners's PTLA Position: Q2 2020 in Review

Jackson Square Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 3,488,146 shares — an estimated $24.9M sold.

Jackson Square Partners first reported a position in PTLA in Q3 2018 and held it in 7 quarters. The position peaked at $86.5M in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Jackson Square Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Jackson Square Partners sold 3,488,146 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $24.9M.
  • Jackson Square Partners first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 7 quarters.
  • Jackson Square Partners's Portola Pharmaceuticals, Inc. position peaked at $86.5M in Q3 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Jackson Square Partners's 13F filing for Q2 2020, filed 7 Aug 2020.